Compare AU

Compare DRUG vs. SUBD

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the Aussie Subordinated Bonds (SUBD). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

SUBD

Popularity

Low

Low

Pearlers invested

63

18

Median incremental investment

$967.00

$4,011.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,921.92

$10,869.49

Average age group

26 - 35

> 35


Key Summary

DRUG

SUBD

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

SUBD.AX was created on 2019-10-28 by VanEck. The fund's investment portfolio concentrates primarily on investment grade fixed income. SUBD.AX invests in a portfolio of subordinated bonds with the aim of providing investment returns before fees and other costs that track the performance of the Index.

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Commonwealth Bank of Australia (8.90 %)

National Australia Bank Ltd. (7.15 %)

ANZ Group Holdings Ltd. (6.31 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.57 %

0.29 %


Key Summary

DRUG

SUBD

Issuer

BetaShares

VanEck

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

iBoxx AUD Investment Grade Subordinated Debt Mid Price Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

0.29 %

Price

$8.25

$25.19

Size

$182.401 million

$2.029 billion

10Y return

N/A

N/A

Annual distribution yield (5Y)

1.90 %

3.58 %

Market

ASX

ASX

First listed date

08/08/2016

30/10/2019

Purchase fee

$6.50

$6.50


Community Stats

DRUG

SUBD

Popularity

Low

Low

Pearlers invested

63

18

Median incremental investment

$967.00

$4,011.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,921.92

$10,869.49

Average age group

26 - 35

> 35


Pros and Cons

DRUG

SUBD

Pros

  • Higher exposure to US market

  • Higher price growth

  • Lower management fee

  • Higher distribution yield

Cons

  • Higher management fee

  • Lower distribution yield

  • Lower exposure to US market

  • Lower price growth

DRUG

SUBD

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home